Treatment with reteplase appears more effective than alteplase in patients with acute ischaemic stroke (AIS) who have been treated within 4.5 hours of symptom onset, according to the results of RAISE, a phase III multicentre, open-label, randomized controlled, noninferiority trial.
Otorhinolaryngologists at the Chinese University of Hong Kong (CUHK) have introduced upper airway stimulation (UAS) as a treatment option for obstructive sleep apnoea (OSA), making Hong Kong one of the three locations in Asia where this surgical intervention is available.
Adding metformin to insulin neither lowers the risk of developing preterm pre-eclampsia nor improves the risk markers of cardiovascular disease in pregnant women who have received a diagnosis of diabetes early in pregnancy or have existing type 2 diabetes mellitus, according to a study.
Use of artificial intelligence (AI) as part of the support system can greatly improve the quality of care in patients who just had a stroke and may even prevent the occurrence of various vascular events in the future, according to a study presented at ISC 2024.
Women who underwent assisted reproductive technology(ART) were significantly more likely to experience strokes during delivery hospitalization than those who did not use ART, according to a study presented at ISC 2024.
A novel smartphone app that uses machine learning algorithms to analyse facial expressions, speech patterns, and arm movements can detect acute stroke and Bell’s palsy with an accuracy matching that of neurologists, as shown in a study.
The risk of developing serious infections is much lower among patients with Crohn’s disease (CD) who showed response to adalimumab therapy than nonresponders, after accounting for disease severity, according to the results of a study presented at CCC 2024.
Multiple biosimilar infliximab (IFX) switching among patients with inflammatory bowel disease (IBD) does not seem to give rise to disease flares at 12 months compared to those who continued using IFX originator or those on single IFX biosimilar switch, a study has shown.